Global Vaccines Market to surpass $65 Bn by 2024: Global Market Insights, Inc.

Global Vaccines Market By Age Group (Pediatric, Adult), By Technology (Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant,), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), Regional Outlook (U.S., Canada, Germany, UK, Spain, Russia, Italy, France, China, Japan, India, Indonesia, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Qatar, Egypt) & Global Forecast (2017 – 2024)


Sellbyville, Delaware, Nov. 20, 2017 (GLOBE NEWSWIRE) --

Global Vaccines Market  is poised to cross USD 65 billion by 2024; according to a new research report by Global Market Insights, Inc. Introduction of innovative technologies in vaccination, rising government support for product development will stimulate global vaccines market growth over the coming years. Growing awareness towards preventive vaccination in pediatric and increasing adoption of therapeutic vaccines in cancer treatment will fuel industry growth.

Increasing disease prevalence in underdeveloped countries coupled with growing incidence of cancer & HIV will serve as high impact rendering factor for the business growth. High cost and inadequate reimbursement coverage for vaccines will hamper industry expansion. Moreover, stringent government regulations for product approval will further restrain business growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2186

Pediatric will grow at a significant rate over the forecast period owing to CDC recommendation for immunization schedule to protect children and infants before getting exposed to potentially life-threatening diseases.

 Attenuated vaccines will grow at a substantial rate over the forecast period pertaining to factors such as robust antibody and cellular responses, and frequently deliberate lifelong immunity with only one or two doses.

Influenza will witness considerable growth due to growing incidence, mounting number of disease-causing microbes (pathogens) and rising awareness in emerging economies towards disease prevention. Availability of vaccines at affordable prices in hospitals and clinics will augment the segment growth.

Browse key industry insights spread across 140 pages with 108 market data tables & 9 figures & charts from the report, “Global Vaccines Market” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/vaccines-market

U.S. vaccines market will witness significant growth over the forecast period pertaining to enormous impact of immunization on improving health of children and protecting them with vaccines due to epidemics of preventable diseases like mumps, pertussis, and measles.

India will witness lucrative growth due to improved efficiency of immunization programs and technological advancements in vaccine storage and transport. Rising per capita income, improved healthcare infrastructure and growing healthcare expenditure will promote business growth.

China vaccines market will grow at a substantial rate owing to rising disposable income, rapid economic growth, rising number of unvaccinated migrant workers, and delivery of efficient healthcare services.

Brazil vaccines market will growth at a considerable rate over the coming years. Availability of vaccines at low cost and rising initiatives by Brazilian government to improve vaccination coverage will stimulate steady business expansion.

Some of the companies operating in industry are Abbott, AstraZeneca, Astellas Pharma, Bristol-Myers Squibb, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Novavax, Pfizer and Sanofi Pasteur.

New product launches and expansion of existing product portfolio will mainly drive the business growth. Major industry participants will endeavor to fortify their market position by adopting these strategies. 

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2186

Browse Related Reports:

  • Companion Animal Vaccines Market Size 2017 – 2024

Companion Animal Vaccines Market is expected to grow at CAGR of above 6 %. It accounted for over 41% of veterinary vaccines market in 2015, which may grow at over 5% and exceed USD 5.6 billion by 2024.
https://www.gminsights.com/industry-analysis/companion-animal-vaccines-market

  • Animal Healthcare Market Size 2017 – 2023

Animal Healthcare Market valued USD 26 billion in 2016 and is expected to grow with a CAGR of nearly 4% during the forecast period. Rapidly increasing pet adoption, growing need to control zoonotic diseases spread and advances in drug development for effective animal health will drive global animal healthcare industry.
https://www.gminsights.com/industry-analysis/animal-healthcare-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with us: Facebook | Google+ | LinkedIn | Twitter